Spring Bank Pharmaceuticals, Inc.

75 articles about Spring Bank Pharmaceuticals, Inc.

• Spring Bank Pharmaceuticals, Inc. Announces Presentation Of Results From Phase I Clinical Trial Supporting The Novel Mechanism Of Action Of SB 9200 In Patients With Hepatitis C At The Liver Meeting

  10/13/2015

• Spring Bank Pharmaceuticals, Inc. Appoints Martin Driscoll As President And Chief Executive Officer

  8/17/2015

• Spring Bank Pharmaceuticals, Inc. Presents Preclinical And Clinical Data On Immunomodulatory Agent SB 9200 At The 2015 Annual Meeting Of The European Association For The Study Of The Liver

  4/27/2015

• Spring Bank Pharmaceuticals, Inc. To Present HBV And HCV Results With SB 9200 At EASL 2015

  4/13/2015

• Spring Bank Pharmaceuticals, Inc. To Present Novel Approach To Hepatitis B Treatment At The 2015 AASLD And Industry Colloquium

  3/12/2015

• Spring Bank Pharmaceuticals, Inc. Completes $22 Million Financing

  2/26/2015

• Jonathan P. Freve, CPA, Joins Spring Bank Pharmaceuticals, Inc. As Vice President Of Finance

  2/26/2015

• Spring Bank Pharmaceuticals, Inc. To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference

  1/28/2015

• Spring Bank Pharmaceuticals, Inc. Announces National Institutes of Health (NIH) Collaboration For Testing Of SB 9200 Against Multiple Viral Pathogens

  9/18/2014

• Spring Bank Pharmaceuticals, Inc. Presents At The Nucleic Acid Summit 2014

  6/23/2014

• Spring Bank Pharmaceuticals, Inc. Announces Oral And Poster Presentations At The 27th International Conference On Antiviral Research

  5/12/2014

• Veteran Biotech Executive David Arkowitz Joins Spring Bank Pharmaceuticals, Inc.' Board Of Directors

  1/28/2014

• Spring Bank Pharmaceuticals, Inc. Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients

  5/23/2013

• Spring Bank Pharmaceuticals, Inc. Closes $10.5 Million Series A Financing

  2/28/2013

• Spring Bank Pharmaceuticals, Inc. Awarded $3.9 Million RO1 National Institutes of Health (NIH) Grant to Advance Innovative Hepatitis Program

  5/5/2011